Homology Medicines, Inc. (FIXX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts FIXX Hot Sheet
Join SI Premium – FREE
Homology Medicines, Inc. (NASDAQ: FIXX) reported Q1 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $867 thousand.
For earnings history and earnings-related data on Homology Medicines, Inc. (FIXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- The LGL Group (LGL) Misses Q2 EPS by 8c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
